Do Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Adversely Impact Fracture Healing? A Critical Review of the Literature
- PMID: 40471521
- PMCID: PMC12361010
- DOI: 10.1007/s12178-025-09983-6
Do Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Adversely Impact Fracture Healing? A Critical Review of the Literature
Abstract
Purpose of review: The purpose of this review was to critically appraise the literature and establish an evidence-based clinical guideline for the use of non-steroidal anti-inflammatory drugs (NSAIDs) in a fracture setting.
Recent findings: With few exceptions, studies in animals suggest that NSAIDs impair fracture healing. It is unclear if nonselective or cyclooxygenase-(COX)2-selective NSAIDs pose differing effects on fracture healing. Human studies show NSAID use to be a consistent risk factor for fracture non-union in skeletally mature populations across the literature and indicates that indomethacin in particular poses a significant risk for non-union of adult acetabular fractures. Current evidence appears to suggest no harm in using ketorolac or ibuprofen in a pediatric fracture population, while indomethacin poses a significant risk for non-union in adult acetabular fracture patients when used for six weeks. Despite the majority of available clinical studies showing NSAID use as a recurring risk factor for fracture non-union in adult populations, a lack of standardization amongst studies makes it difficult to determine any clinical recommendations about timing, dosage, duration, or type of agent administered. More high-quality prospective studies are needed.
Keywords: Bone healing; Cyclooxygenase; Fracture; Non-steroidal anti-inflammatory Drugs; Non-union.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Competing Interests: Sarah G. Stroud, Lara Passfall, Juhayer S. Alam, Frank (A) Segreto, Rachel Baum, Neil V. Shah, Jad Bou Monsef, and Carl (B) Paulino declare that they have no conflict of interest. Bassel G. Diebo reports he has received speaker/consulting honorarium from Clariance, Spineart, and Spinevision, and research support from Alphatec Spine and Medtronic.
References
-
- Ramsey L. The 10 most popular prescription drugs in the US. Business Insider. 2017.
-
- Sivaganesan A, Chotai S, White-Dzuro G, McGirt MJ, Devin CJ. The effect of NSAIDs on spinal fusion: a cross-disciplinary review of biochemical, animal, and human studies. Eur Spine J. 2017;26:2719–28. - PubMed
-
- Whalen K, Finkel R, Panavelil TA. Lippincott Illustrated Reviews: Pharmacology 6th edition. 6th edition. Wolters Kluwer; 2016.
-
- Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997;49:15–9. - PubMed
-
- Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Isakson P. Distribution of Cox-1 and Cox-2 in Normal and Inflamed Tissues. 1997. pp. 167–70. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials